Results

Total Results: 112 records

Showing results for "risk".

21. Million Hearts Baseline 10 Year Ascvd Risk Change Log
    cds.ahrq.gov/sites/default/files/cds/artifact/logic/2021-09/Million_Hearts_Baseline_10_Year_ASCVD_Risk_Change_Log.txt
    January 01, 2021 - Year_ASCVD_Risk_FHIRv102 version 1.0.2 was used in a 2019 pilot to calculate the estimated 10-year CVD risk

22. Mental Health: Positive Suicide Risk Screening Order Set | CDS Connect
    cds.ahrq.gov/cdsconnect/artifact/mental-health-positive-suicide-risk-screening-order-set
    April 27, 2018 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates

23. Primary Care Management Guidance for Fall Risk-Increasing Drugs | CDS Connect
    cds.ahrq.gov/cdsconnect/artifact/primary-care-management-guidance-fall-risk-increasing-drugs
    June 08, 2022 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates

24. CDS Connect Work Group June 2021 Summary (pdf file)
    cds.ahrq.gov/sites/default/files/workgroups/13461/CDS_Connect_WG_June_2021_Summary_0.pdf
    January 01, 2021 - based on the PDDI safety profile and patient risk factors. … Many levels of risk review have been established for potentially clinically harmful PDDIs. … chart (known as the “patient-view hook”) to enable shared decision making (SDM) on the benefits and risks … understand PDDIs, especially in instances where the benefits of some drug combinations might outweigh the risks … factors to produce a risk array that visually represents the estimated risk of an adverse side effect

25. Jan-2017-Cholesterol-Wg-Notes (doc file)
    cds.ahrq.gov/sites/default/files/workgroups/216/jan-2017-cholesterol-wg-notes.docx
    January 01, 2017 - risk calculation and/or presentation of the risk assessment tool: · Application as a population health … Kaiser has both an on-demand risk calculator that can produce real-time risk scores but no recommendations … For this reason, the USPTF recommendation to calculate ASCVD risk only when 1 or more risk factor is … The WG also debated the merits of using multiple risk tools for cardiovascular risk, and whether there … of cardiovascular disease, but the potential impact of statin therapy, and in turn, the risks associated

26. CMS's Million Hearts® Model Longitudinal ASCVD Risk Assessment Tool | CDS Connect
    cds.ahrq.gov/cdsconnect/source/cmss-million-heartsr-model-longitudinal-ascvd-risk-assessment-tool
    April 07, 2025 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates

27. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Patient-Facing CDS Intervention (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1056/2024_CDS_Connect_IG_Statin_CVD_Patient_Facing_2.pdf
    January 01, 2024 - • Provide educational resources about the risks for developing CVD and the role that statin therapy … factors, and identification of resources to address those risks. … Suggested Action: Provide educational materials that explain CVD risks pertinent to this recommendation … levels” instead of clinical descriptions), along with ways to modify those risks, such as taking a … Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients

28. Apr-2017-Cholesterol-Wg-Notes (doc file)
    cds.ahrq.gov/sites/default/files/workgroups/231/apr-2017-cholesterol-wg-notes.docx
    January 01, 2017 - The ACC/AHA provides a statin recommendation for risk scores 5-<=7.5% and USPSTF provides one for 7.5 … <10%. · CAMH may consider a way to allow users to change the risk score parameter if the appropriate … It influences a patient’s risk, but not as much as someone with a clinical event. … More work has been done on the inpatient side related to bleeding risks. … At a certain point, an elevated SBP is risk.

29. Warfarin-Antidepressants Mdia Implementation Guide (doc file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1146/Warfarin-Antidepressants%20MDIA%20Implementation%20Guide.docx
    August 29, 2020 - Implementing and Using This Artifact Description and Purpose of the artifact This artifact aims to address risks … Although there are concerns regarding bleeding risks associated with warfarin and antidepressants, only … Recommendation: Use only if benefit outweighs risk · Rationale: Increased GI and non-GI bleeding risk … 20 MG Oral Tablet None Assess risk and take action if necessary Increased GI and non-GI bleeding risk … risk is likely 1528 18 Warfarin / SSRI or SNRI with major bleeding risk factors Warfarin Sodium

30. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Clinician-Facing CDS Intervention (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/18/2024_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdf
    January 01, 2024 - appointment, the primary care clinician provides educational information to the patient about their personal risks … factors, and identification of resources to address those risks. … Patient has a terminal condition, and the risks of preventive treatment outweigh benefits. … CVD risk is calculated using the 2013 ACC/AHA ASCVD Risk Estimator or the ACC Risk Estimator Plus with … Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients

31. CDS Connect Implementation Guide Draft (doc file)
    cds.ahrq.gov/sites/default/files/cds/artifact/81/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Updated%20Risk_Final_0.docx
    October 01, 2017 - Implementation Guide Longitudinal ASCVD Risk Assessment Tool for Updated 10-Year ASCVD Risk Prepared … to address this risk. 2. … The Updated Risk calculation compares the original Baseline risk with the Updated risk based on interventions … Provide information resources to the patient outlining benefits, risks, effects, and evidence behind … Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients

32. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Patient-Facing CDS Intervention (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1056/2023_CDS_Connect_IG_Statin_CVD_Patient_Facing.pdf
    January 01, 2023 - • Provide educational resources about the risks for developing CVD and the role that statin therapy … factors, and identification of resources to address those risks. … Suggested Action: Provide educational materials that explain CVD risks pertinent to this recommendation … levels” instead of clinical descriptions), along with ways to modify those risks, such as taking a … Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients

33. CDS Connect Implementation Guide Draft (doc file)
    cds.ahrq.gov/sites/default/files/cds/artifact/76/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Shared%20Decision%20Making_Final_0.docx
    October 01, 2017 - to address this risk. 2. … on his overall cardiac risk. … The risk score display is presented as part of the assessment, showing his current risk. … Provide the patient with information resources that outline benefits, risks, effects, and evidence behind … Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients

34. AHRQ PCOR CDS Project Kickoff (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/476/Pilot%20Site%20Training%20for%20Pain%20Management%20Summary%20CDS_for%20Repository_0.pdf
    July 23, 2024 - Non-pharmacologic & non-opioid therapies preferred ▪ Establish treatment goals with patients ▪ Assess and discuss risks … and benefits – Prescribe naloxone if at high risk ▪ Prescribe immediate-release opioids ▪ Prescribe … the lowest effective dose ▪ Monitor PDMP – ≤50 MME/day preferred – ≥90 MME/day is high risk ▪ Urine … screenings relevant to pain management – all within the past 1 year – Opioid Risk Tool, PHQ 2, PHQ … – Always flag if present: “Factor that may place the patient at risk for an opioid-related harm.”

35. Dec-2016-Cholesterol-Wg-Notes (doc file)
    cds.ahrq.gov/sites/default/files/workgroups/211/dec-2016-cholesterol-wg-notes.docx
    January 01, 2016 - ASCVD risk after interventions have been initiated) · PQRS #438 – Statin use for Primary Prevention … · MESA CAC Score, which can double or triple a patient’s risk that was estimated by a calculator. … This score uses a sub-clinical marker, but does not estimate the risk of stroke. … The USPTF guidelines send the clinician to the calculator only if at least 1 risk factor is present. … Assessment Tool (determine if use of this tool occurs immediately if no ASCVD or if at least 1 risk

36. Osteoporosis Patient Handout (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/136331/Bisphosphonates%20Patient%20Handout.pdf
    July 18, 2023 - Bisphosphonates are the safest choice for most people like you, who have thin or fragile bones, because this risks … of falling and breaking a bone are greater than the risks of side effects. … Weighing the risks and benefits How to take it: There are several different types of bisphosphonates

37. Osteoporosis Patient Handout (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/66551/Bisphosphonates%20Patient%20Handout.pdf
    July 18, 2023 - Bisphosphonates are the safest choice for most people like you, who have thin or fragile bones, because this risks … of falling and breaking a bone are greater than the risks of side effects. … Weighing the risks and benefits How to take it: There are several different types of bisphosphonates

38. Healthy Diet and Physical Activity for CVD Prevention in Adults With Cardiovascular Risk Factors | CDS Connect
    cds.ahrq.gov/cdsconnect/artifact/healthy-diet-and-physical-activity-cvd-prevention-adults-cardiovascular-risk
    June 01, 2019 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates

39. Warfarin-Nsaids Mdia Implementation Guide (doc file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1141/Warfarin-NSAIDs%20MDIA%20Implementation%20Guide.docx
    November 11, 2019 - Implementing and Using This Artifact Description and Purpose of the artifact This artifact aims to address risks … · For Warfarin – NSAIDS rule: · Recommendation: Assess risk and take action if necessary · Rationale … : Possible increased risk of bleeding · Class 1: Red: Avoid Combination · For Warfarin – NSAIDS rule: … · Recommendation: Use only if benefit outweighs risk · Rationale: Increased bleeding risk likely … and take action if necessary Possible increased risk of bleeding 1496 56 Patient is not on PPI

40. Warfarin And Ssris Graph V. 5 (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1146/Warfarin%20and%20SSRIs%20Graph%20V.%205.pdf
    May 18, 2020 - Warfarin Type of Antidepressant Assess risk … and take action if necessary Increased GI and non-GI bleeding risk is possible Assess risk and … Increased bleeding risk unlikely And SNRIs: clomipramine, desvenlafaxine, duloxetine, … No Yes Use only if benefit outweighs risk Increased GI and non-GI bleeding risk is likely … RED: Class 1: Avoid Combination YELLOW: Class 2/3: Usually Avoid Combination or Minimize Risk GREEN